Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR

Classement en actions #36451
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Prix de l'action
$1.73
Dernière synchronisation: 2025-06-17
Capitalisation boursière
$2.55M
Changement (1 jour)
-0.29%
Changement (1 an)
-79.71%
Pays
US
Échange Eiger BioPharmaceuticals, Inc. (EIGR)

Catégorie

Healthcare
Historique des divisions d’actions pour Eiger BioPharmaceuticals, Inc. (EIGR)
L’action Eiger BioPharmaceuticals, Inc. (symbole : EIGR) a subi un total de 2 divisions.
La division la plus récente a eu lieu le Jan 08, 2024.
Une action EIGR achetée avant le Mar 23, 2016 équivaudrait aujourd’hui à 0.0022222222222222 actions EIGR.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2024-01-08 1:30 x0.033333333333333 x0.0022222222222222
2016-03-23 1:15 x0.066666666666667 x0.066666666666667
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL